Roth Capital raises Travelers target to $425

1 min read | Published on 06 Jul 2026, 10:44 PM |Updated on 22 Jul 2026, 02:47 AM

Reviewed by

Radhika SScanX News Team

Key Highlights

Roth Capital analyst Harry Fong maintained a Buy rating on Travelers Companies and raised the price target to $425 from $345. This update comes alongside various other analyst ratings, including Underweight, In-Line, and Strong Buy, with targets ranging from $307 to $425.

*this image is generated using AI for illustrative purposes only.

Roth Capital analyst Harry Fong has maintained a Buy rating on Travelers Companies while raising the price target to $425 from $345. This revision reflects an updated valuation outlook for the insurance provider, which trades on the NYSE under the ticker TRV. The adjustment aligns with a broader trend of financial institutions reassessing the stock's market performance and potential.

Rating and Price Target

The research note retains a positive investment stance on Travelers Companies alongside the increased price objective. The table below summarizes the recent analyst actions:

Firm	Analyst	Rating	Price Target	Previous Target
Roth Capital	Harry Fong	Buy	$425	$345
Barclays	Alex Scott	Underweight	$318	$295
Morgan Stanley	Bob Huang	Underweight	$330	$290
B of A Securities	Joshua Shanker	Underperform	$307	$283
Evercore ISI Group	David Motemaden	In-Line	$329	$321
Wells Fargo	Elyse Greenspan	Equal-Weight	$334	$295
Mizuho	Yaron Kinar	Neutral	$324	$304
Raymond James	C. Gregory Peters	Strong Buy	$400	$350

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What factors could drive further divergence between Roth Capital's bullish outlook and the more cautious stances of other analysts?

How might Travelers' upcoming earnings reports influence the broader consensus on its valuation?

What market conditions or industry trends could support the realization of the $425 price target?

BMO downgrades Travelers to Market Perform, raises target to $379

0 min read | Published on 20 Jul 2026, 09:34 PM |Updated on 21 Jul 2026, 04:32 PM

Reviewed by

Radhika SScanX News Team

Add as a preferred
source on Google

Key Highlights

BMO Capital downgraded Travelers Companies to Market Perform from Outperform, raising the price target to $379 from $314. Citigroup maintained a Neutral rating with a raised target of $385, while Evercore ISI kept an In-Line rating with a target of $338.

*this image is generated using AI for illustrative purposes only.

BMO Capital analyst Michael Zaremski has downgraded Travelers Companies to Market Perform from Outperform and raised the price target to $379 from $314. This adjustment reflects a revised valuation outlook for the insurance provider. Separately, Citigroup analyst Matthew Heimermann maintained a Neutral rating on Travelers Companies and raised the price target to $385 from $315. Evercore ISI Group analyst David Motemaden previously maintained an In-Line rating on Travelers Companies with a price target of $338, raised from $329.

Rating and Target Details

The revised price target of $379 from BMO Capital represents an increase from the previous target of $314. The downgrade to Market Perform indicates a more neutral stance on the company's performance. Citigroup's revised target of $385 also signifies a significant increase from its prior target of $315, while maintaining a Neutral rating.